Allogeneic stem cell transplant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic stem cell transplant, covering 2025-10-16 to 2025-10-16. Get the full timeline:
Most recent: Clinical Trial Update: 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome [Phase 1, Phase 2]